or
forgot password

    • cancer clinical trials in syracuse, NY

    • Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum
    Veterans Affairs Medical Center - Syracuse

    Trial Locations
    Veterans Affairs Medical Center - Syracuse
    SUNY Upstate Medical University Hospital
    Colorectal Cancer
    Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma
    Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Leukemia
    Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
    SUNY Upstate Medical University at Syracuse
    Syracuse, New York 13210
    Glioblastoma Multiforme
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    SUNY Upstate Medical University

    Trial Locations
    SUNY Upstate Medical University
    Syracuse VA Medical Center
    Non Small Cell Lung Carcinoma
    Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Cervical Cancer
    BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Lymphoma, Non-Hodgkin
    XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Biliary Tract Cancer
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Brain and Central Nervous System Tumors
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Syracuse Hematology/Oncology PC
    Syracuse, New York 13210
    Multiple Myeloma
    Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific
    Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Brain and Central Nervous System Tumors
    Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Veterans Affairs Medical Center - Syracuse

    Trial Locations
    Veterans Affairs Medical Center - Syracuse
    SUNY Upstate Medical University Hospital
    Lung Cancer
    Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific
    Group Therapy for Primary Breast Cancer
    Syracuse Hem/Onc CCOP
    Syracuse, New York 13210
    Breast Cancer
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    SUNY Upstate Medical University

    Trial Locations
    SUNY Upstate Medical University
    Scottish Rite Children's Medical Center
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    State University of New York Upstate Medical University

    Trial Locations
    State University of New York Upstate Medical University
    Community General Hospital
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
    SUNY Upstate Medical University - Regional Oncology Center
    Syracuse, New York 13210
    Small Cell Lung Cancer
    Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Brain and Central Nervous System Tumors, Neurofibromatosis Type 1
    A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Carcinoma, Non-Small-Cell Lung
    Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
    SUNY Upstate Medical Center
    Syracuse, New York 13210
    Small Cell Lung Cancer
    Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
    State University of New York Upstate Medical University
    Syracuse, New York 13210
    B-cell Childhood Acute Lymphoblastic Leukemia, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia
    A Safety and Efficacy Study of Patients Requiring Sedation During Monitored Anesthesia Care (MAC)
    SUNY Upstate Medical Center
    Syracuse, New York 13210
    Anesthesia, Surgical Procedures, Elective
    A Study of Abatacept in Patients With Active Crohn's Disease
    University Endoscopy Center
    Syracuse, New York 13210
    Crohn's Disease
    A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
    SUNY Upstate Medical Center
    Syracuse, New York 13210
    Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Leukemia
    Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
    Upstate Medical University
    Syracuse, New York 13210
    Cutaneous T-cell Lymphoma (CTCL),
    Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
    SUNY Upstate Medical University Hospital
    Syracuse, New York 13210
    Malignant Mesothelioma
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    SUNY Upstate Medical University - Regional Oncology Center
    Syracuse, New York 13210
    Small Cell Lung Cancer
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Multiple Sclerosis, Relapsing-Remitting
    Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen
    Sanofi-Aventis Investigational Site Number 840097

    Trial Locations
    Sanofi-Aventis Investigational Site Number 840097
    Sanofi-Aventis Investigational Site Number 840017
    Colorectal Neoplasms, Neoplasm Metastasis
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    SUNY - Upstate Medical University Div. of Hematology-Oncology
    Syracuse, New York 13210
    Multiple Myeloma
    Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
    Sanofi-Aventis Investigational Site Number 840015
    Syracuse, New York 13210
    Urinary Bladder Neoplasms
    Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase
    Upstate Medical University SUNY
    Syracuse, New York 13210
    Hunter Syndrome, Mucopolysaccharidosis II
    Perceptions of Touch in People With Cancer
    SUNY UMU
    Syracuse, New York 13210
    Cancer
    Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Regional Osteoporosis as a Result of Chemotherapy
    False/Negative Rate of Lung Percutaneous Needle Biopsy
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Lung Neoplasm
    Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Lung Neoplasm
    Evaluation of MRI and SPECT Fusion Software to Localize Parathyroid Adenomas
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Parathyroid Neoplasm, Parathyroid Diseases
    Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
    Upstate Medical University
    Syracuse, New York 13210
    Non-small Cell Lung Cancer (NSCLC)
    Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
    State University of New York Upstate Medical University
    Syracuse, New York 13210
    Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue
    SUNY Upstate Medical University
    Syracuse, New York 13210
    Fibromyalgia, Primary
    Cognition in the Study of Tamoxifen and Raloxifene
    University Healthcare System
    Syracuse, New York 13202
    Cognition, Aging